Bartus Cynthia L, Katz Kenneth A
University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
J Am Acad Dermatol. 2006 Jul;55(1):116-22. doi: 10.1016/j.jaad.2006.01.046.
Problems in some advertisements in medical journals, including dermatology journals, have been identified in various studies. Examples have included poorly supported claims, failure to balance claims of efficacy with potential adverse effects of a drug, and slogans that recommend prescribing a drug for groups of patients different from those assessed in a referenced study.
We sought to assess dermatology journals' and dermatology journal editors' policies, practices, and attitudes toward prescription-medicine advertising in dermatology journals.
We searched dermatology journals' paper copies and World Wide Web sites for statements of advertising policy and sent surveys to dermatology journal editors.
Of 22 journals, 8 (36.4%) had an advertising policy published in a paper copy or a World Wide Web site. Of 17 editors (70.8%) from 17 journals (77.3%) who responded to the survey, 3 reported having an advertising policy; these policies were also identified in searches of paper copies or World Wide Web sites. Two editors whose journals each had a published policy reported not having one. In all, 7 editors (41.2%) reported that they or other physician members of the editorial board reviewed advertisements before publication in the previous year. A total of 8 editors (47.1%) agreed somewhat or strongly that advertisements in medical journals, including dermatology journals, generally present information that is accurate, and 12 (70.6%) agreed somewhat or strongly with the same statement regarding advertisements appearing in their own journal. In all, 12 editors (70.6%) agreed somewhat or strongly that advertisements should be reviewed for accuracy by the editorial staff before publication, and 3 (17.6%) agreed somewhat or strongly that advertisements should be reviewed for accuracy before publication in a peer-review process similar to that used for submitted manuscripts.
This study did not assess processes by which editors or other members of editorial or publishing staffs review advertisements before publication.
Policies, practices, and attitudes toward advertising vary among dermatology journals and dermatology journal editors. Journals, especially those without a policy, should consider establishing policies to separate and, therefore, minimize conflicts of interest between editorial and business aspects of publication.
多项研究已发现医学期刊(包括皮肤科期刊)中部分广告存在问题。例如,广告声称缺乏充分依据、未能在药物疗效声明与潜在不良反应之间取得平衡,以及推荐为与参考研究中评估的患者群体不同的患者群体开药的口号。
我们试图评估皮肤科期刊及皮肤科期刊编辑针对皮肤科期刊中处方药广告的政策、做法和态度。
我们查阅了皮肤科期刊的纸质版和网站以获取广告政策声明,并向皮肤科期刊编辑发送了调查问卷。
在22种期刊中,8种(36.4%)在纸质版或网站上发布了广告政策。在回复调查的17种期刊(77.3%)的17位编辑(70.8%)中,3位报告有广告政策;这些政策在纸质版或网站搜索中也被找到。有两位编辑所在的期刊各自都发布了政策,但他们却报告没有。总体而言,7位编辑(41.2%)报告称他们或编辑委员会的其他医师成员在去年广告发表前进行了审查。共有8位编辑(47.1%) somewhat或强烈同意医学期刊(包括皮肤科期刊)中的广告通常呈现准确信息,12位(70.6%) somewhat或强烈同意关于其所在期刊上出现的广告的相同表述。总体而言,12位编辑(70.6%) somewhat或强烈同意广告在发表前应由编辑人员审查准确性,3位(17.6%) somewhat或强烈同意广告应在类似于用于提交稿件的同行评审过程中在发表前审查准确性。
本研究未评估编辑或编辑或出版工作人员的其他成员在广告发表前进行审查的过程。
皮肤科期刊和皮肤科期刊编辑对广告的政策、做法和态度各不相同。期刊,尤其是那些没有政策的期刊,应考虑制定政策以区分并因此尽量减少出版编辑和商业方面之间的利益冲突。